EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSBGRG00000019181
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSBGRG00000007329
Gene Symbol: TLR9
1 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSBGRG00000020606
Gene Symbol: TAAR1
1 Cross references
600 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSBGRG00000020338
Gene Symbol: TGFBR1
1 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSBGRG00000013391
Gene Symbol: TRPA1
1 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSBGRG00000014019
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSBGRG00000021585
Gene Symbol: TRPV1
1 Cross references
134 Possible Orthologues:

Transthyretin

Ensembl ID : ENSBGRG00000022634
Gene Symbol: TTR
1 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSBGRG00000012473
Gene Symbol: TPH1
1 Cross references
257 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSBGRG00000001452
Gene Symbol: TUBA1B
1 Cross references
92 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSBGRG00000001528
Gene Symbol: TUBA1C
1 Cross references
128 Possible Orthologues:

Tubulin Alpha 3c

Ensembl ID : ENSBGRG00000013042
Gene Symbol: TUBA3C
1 Cross references
150 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).